QURETEC
Desconocido
SZ_TEST: Towards Early Molecular Diagnostics of Schizophrenia
OU QURETEC
participó en un
H2020:
H2020-MSCA-RISE-2016
Schizophrenia (SZ) is a severe mental disorder affecting more than 0.7% of the adult population. One of the most disabling and emotionally d...
2016-12-05 - 2022-06-30 | Financiado
2016-12-05 - 2022-06-30 | Financiado
ESNATS: Embryonic Stem cell based Novel Alternative Testing Strategies
OU QURETEC
participó en un
FP7:
"ESNATS aims at developing a novel toxicity test platform based on embryonic stem cells (ESC), especially human ESC (hESC), to accelerate dr...
Financiado
Financiado
DETECTIVE: Detection of endpoints and biomarkers of repeated dose toxicity using in vitro systems
OU QURETEC
participó en un
FP7:
Assessment of repeated dose toxicity is a standard requirement in human safety evaluation and relies on animal testing as no alternatives ar...
Financiado
Financiado
AGEDBRAINSYSBIO: SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING
OU QURETEC
participó en un
FP7:
In spite of valuable approaches applied to get a broad understanding of genetic, epidemiologic and molecular and system-level biological pri...
Financiado
Financiado
* No se disponen de datos de la empresa actual.